Abstract
Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various cancer cells. There have been some reports of acneiform skin lesions that occurred in the cancer patients treated with ZD1839(Iressa®), an inhibitor of EGF tyrosine kinase. We report a case of acneiform eruption related to the anticancer drug, ZD1839(Iressa®).
| Original language | English |
|---|---|
| Pages (from-to) | 478-481 |
| Number of pages | 4 |
| Journal | Korean Journal of Dermatology |
| Volume | 42 |
| Issue number | 4 |
| State | Published - Apr 2004 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acneiform eruption
- ZD1839
Fingerprint
Dive into the research topics of 'A case of acneiform skin eruption associated with ZD1839(Iressa®)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver